Stocks rise as Wall Street reviews latest company earnings


A Wall Street sign is shown in the Financial District, Wednesday, Oct. 13, 2021, in the Manhattan borough of New York. Stocks are opening mostly higher on Wall Street Tuesday, April 19, 2022, as more earnings reports from big companies roll in. (AP Photo/John Minchillo, File)

NEW YORK (AP) — Stocks rose in morning trading on Wall Street Tuesday as investors continue reviewing earnings reports from big companies.

The S&P 500 rose 1% as of 10:24 a.m. Eastern. The Dow Jones Industrial Average rose 343 points, or 1%, to 34,753 and the Nasdaq rose 1.3%.

Health care companies had some of the biggest gains. Johnson & Johnson rose 3.4% after reporting surprisingly good earnings while also raising its dividend. Several medical device makers also made solid gains. Intuitive Surgical rose 5.8% and Boston Scientific rose 4.5%.

Banks gained ground along with rising Treasury yields, which allows them to charge higher interest rates on loans. The yield on the 10-year Treasury rose to 2.91% from 2.85% late Monday. Bank of America rose 1.9%.

Energy stocks lagged the broader market. U.S. crude oil prices slipped 4.3%. Natural gas prices slumped 8.4%.

Wall Street is increasingly focusing on the latest round of corporate report cards as more big companies release earnings. Signature Bank jumped 5.2% after beating analysts' earnings expectations. Netflix is on deck to report earnings after the market closes Tuesday. Railroad giant CSX will report earnings on Wednesday, along with Tesla. American Airlines and Union Pacific will report their results on Thursday.

The latest round of earnings comes as investors try to gauge how companies and consumers are dealing with rising inflation that has made everything from food to clothing and gas more expensive.

The conflict in Ukraine has added to those price pressures. The International Monetary Fund on Tuesday downgraded the outlook for the world economy this year and next, blaming Russia’s war in Ukraine for disrupting global commerce, pushing up oil prices, threatening food supplies and increasing uncertainty already heightened by the coronavirus and its variants.


Rising prices have prompted the Federal Reserve and other central banks to raise interest rates in order to help temper inflation’s impact. The Fed has already announced a quarter-percentage point rate hike and Wall Street expects a half-percentage rate hike at its next meeting.

Bond yields have been rising as Wall Street prepares for higher interest rates. The yield on the 10-year Treasury is the highest it's been since late in 2018. Rising yields have also been raising pressure on an already tight housing market as mortgages rates rise and make borrowing more expensive. Wall Street will get more details on that impact when the National Association of Realtors releases its homes ales report for March on Wednesday.

Should you invest $1,000 in Johnson & Johnson right now?

Before you consider Johnson & Johnson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson & Johnson wasn't on the list.

While Johnson & Johnson currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Union Pacific (UNP)
4.3898 of 5 stars
$242.79-0.3%2.14%23.17Moderate Buy$258.78
Signature Bank (SBNY)
0 of 5 stars
$3.35flatN/AN/AN/A
Johnson & Johnson (JNJ)
4.9366 of 5 stars
$146.14-0.5%3.39%9.11Hold$175.86
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

JNJ shares hit a low, trading near $145 at under 14X earnings. With a high dividend yield, it's poised for a rebound.

Search Headlines: